Unknown

Dataset Information

Etanercept exacerbates inflammation and pathology in a rabbit model of active pulmonary tuberculosis.


ABSTRACT: Treatment of chronic inflammatory diseases with tumor necrosis factor alpha (TNF-α) antagonists has been associated with increased risk of tuberculosis (TB). We examined the usefulness of the rabbit model of active pulmonary TB for studying the impact of the human immune modulatory reagent etanercept on the host immune response. Control of Mycobacterium tuberculosis (Mtb) infection, disease pathology, and the global transcriptional response in Mtb-infected lungs of rabbits were studied. Etanercept treatment exacerbated disease pathology and reduced bacillary control in the lungs, compared with infected untreated animals. Reduced collagen and fibrin deposition in the granulomas was associated with significant downregulation of the collagen metabolism and fibrosis network genes and upregulat

SUBMITTER: Tsenova L 

PROVIDER: S-EPMC4150396 | biostudies-literature | 2014 Sep

REPOSITORIES: biostudies-literature